AzTrials
AzTrials

AnesthesiaFIVANCT02666027

The Use of the Fluid IV Alert Monitor to Decrease the Incidence of Undetected Empty IV Bag in Dimmed Operating Rooms

A study testing Fluid Intravenous Alert (FIVA) 'on' and Fluid Intravenous Alert (FIVA) 'off' in people with Anesthesia, run by Nova Scotia Health Authority.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is being performed to determine the effectiveness of Fluid Intravenous Alert (FIVA) in monitoring intravenous fluid delivered to patients under anesthesia in a dimmed ambient light in the operating room. Read more about this study

Who is it for?
Any age
Conditions the study is for
Anesthesia
What is being tested?
Fluid Intravenous Alert (FIVA) 'on' and Fluid Intravenous Alert (FIVA) 'off'
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
90 participants
Where
No sites listed yet
Study dates
Jan 2015to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Attending anesthesiologists scheduled for elective surgical procedures at the Queen Elizabeth II Health Sciences Centre (QEII).

Who cannot join

  • Attending anesthesiologists scheduled for elective surgical procedures at the QEII with cases where lights to not dimmed.

About this study

Official title: The Use of the Fluid IV Alert (FIVA) Monitor to Decrease the Incidence of Undetected Empty Intravenous Bag in Dimmed Operating Rooms

This study is being performed to determine the effectiveness of Fluid Intravenous Alert (FIVA) in monitoring intravenous fluid delivered to patients under anesthesia in a dimmed ambient light in the operating room.

Read the detailed description

Background and Rationale

The first intravenous (IV) system was developed by Dr. Thomas Latta in 1832 to treat Cholera patients. Following its introduction, the IV delivery system has been widely adopted as a means of fluid resuscitation, rehydration and administration of blood products, medications and vasopressors. Today, it is a standard practice to place an IV catheter in all patients requiring an operation in the hospital setting. Intravenous fluid is administered through the IV tubing into the vein and carries the drugs that are needed for induction and maintenance of anesthesia. This IV fluid comes in several varieties which contain different amount of electrolytes, glucose, acidity or starch and is stored in a variety of volumes in sterile bags (most commonly 500 ml and 1000 ml). Once connected to the IV catheter through the IV tubing, the fluid bag is hung on the IV pole above the patient and flow into the patient by gravity.

In the nursing wards, IV fluids are routinely administered via infusion pumps, which can deliver fluid at specified rates and volumes and would sound alarms when the selected volumes of fluid have been completed. While this is an effective means of administering IV fluid, it is a time-consuming process to set up the IV fluid pump and program the infusion volume and rate. Perioperative fluid administration is a rapidly changing process and most anesthesiologists would prefer more control over the rate than pre-programed pumps. In the operating room environment, the rate and manner of drug and fluid administration are highly variable. Therefore, almost all IV fluid administered systems are gravity-fed.

In busy operating rooms, anesthesiologists carefully observe the progress of surgery and the anesthetic state of patients through different monitors. Intravenous fluid bags often run empty unnoticed because the IV fluid bags are hung above the eye level of the anesthesiologist. Even a vigilant anesthesiologist may not be able to promptly detect dry the IV fluid bag. In a previous observational study, the incidence of undetected dry IV bags has been shown to be 29.6%. However, the length of time before an empty bag is noticed is unknown. According to a recent survey about the working conditions in the operating room, including 471 surgeons and 405 nurses, most of the reported intra-operative hazards were due to insufficient illumination of the operating room especially during dangerous situations, such as unexpected bleeding. In the presence of dimmed ambient light in the operating room, e.g. during endoscopic surgeries, it is probably more difficult to visually monitor the flow of IV fluid with higher incidence of undetected dry IV bags. Several potential clinical adverse events can occur if the dry IV bag is not detected promptly. Firstly, if the gravity-fed IV fluid is being used as a carrier to administer drugs, such as anesthetics for total intravenous anesthesia (TIVA), or the infusion of vasopressors, awareness under anesthesia or unstable hemodynamics may occur. Secondly, during fluid or volume resuscitation, the IV fluid delivery system is frequently pressurized in order to deliver fluid as quickly as possible to the unstable patient. The pressurized IV fluid bag can force the air present in the IV fluid bag into the IV tubing when the fluid runs out. This can potentially cause air embolism. Finally, undetected dry IV bags can disrupt fluid flow through the catheter into the patient, allowing blood to pool around the catheter. If a clot is formed, it will occlude the line and prevent any further fluid flow. This may necessitate recannulation of the anesthetized patient during surgery which may be technically challenging.

The FIVA™ (EngenuityMED, Halifax, Canada) is a small, handheld, battery operated, device class I medical device in Canada. It is designed to alarm and alert the physician to change the IV bag when the fluid level in the chamber of the IV set is low. It also functions to stop the fluid flow through the gravity-fed tubing system when the alarm is triggered, preventing air from entering the IV tubing.

We hypothesize that the FIVA would decrease the incidence of unnoticed dry IV bags during surgery, particularly when the operating room lights are dimmed and would therefore decrease the risks associated with undetected dry IV bags.

Conditions
Anesthesia
Being tested
Fluid Intravenous Alert (FIVA) 'on', Fluid Intravenous Alert (FIVA) 'off'
Keywords
Fluid monitoring

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fluid Intravenous Alert (FIVA) 'on'Device

    Fluid Intravenous Alert (FIVA) 'on' - The FIVA™ (EngenuityMED, Halifax, Canada) is a small, handheld, battery operated, device class I medical device in Canada (Figure 1). It is designed to alarm and alert the physician to change the IV bag when the fluid level in the chamber of the IV set is low. It also functions to stop the fluid flow through the gravity-fed tubing system when the alarm is triggered, preventing air from entering the IV tubing. We hypothesize that the FIVA would decrease the incidence of unnoticed dry IV bags during surgery, particularly when the operating room lights are dimmed and would therefore decrease the risks associated with undetected dry IV bags.

  • Fluid Intravenous Alert (FIVA) 'off'Device

    The FIVA will be turned off. - The FIVA™ (EngenuityMED, Halifax, Canada) is a small, handheld, battery operated, device class I medical device in Canada. It is designed to alarm and alert the physician to change the IV bag when the fluid level in the chamber of the IV set is low. It also functions to stop the fluid flow through the gravity-fed tubing system when the alarm is triggered, preventing air from entering the IV tubing. We hypothesize that the FIVA would decrease the incidence of unnoticed dry IV bags during surgery, particularly when the operating room lights are dimmed and would therefore decrease the risks associated with undetected dry IV bags.

Study groups in NCT02666027
Study groupRoleWhat they receive
FIVA ONExperimentalThe FIVA will be turned on for cases randomized to an even number. The ON light will be covered by tape. Routine induction and maintenance of anesthesia and rate and manner of delivery of IV fluid will be administered at the discretion by the anesthesiologist. The FIVA monitor will only monitor the first IV fluid bag since the study will be unblinded once the FIVA monitor alarm is triggered. When the IV bag is empty and the FIVA alarm is triggered, the anesthesiologist will turn off the FIVA and change the IV bag. The following will be recorded by the anesthesiologist: Type of surgical procedure; Duration of surgery; Presence of air in the IV; Number of false alarms triggered by the FIVA during the procedure; VAS assessment of ease of use of the FIVA; Loudness of audial alarm of the FIVA.
Receives: Device: Fluid Intravenous Alert (FIVA) 'on'
FIVA OFFPlacebo comparatorThe FIVA will be off for cases randomized to odd numbers. The indicator lights will be covered by tape. Routine induction and maintenance of anesthesia and rate/manner of delivery of IV fluid will be administered at the discretion of the anesthesiologist. The IV bag may run dry with or without being noticed by the anesthesiologist. When they detect the empty bag, it will be changed after the removal of the FIVA. The anesthesiologist will record the presence or absence of air in the IV tubing following the termination of the study. The following will be recorded by the anesthesiologist: Type of surgery; Duration of surgery; Presence of air in the IV; Number of false alarms triggered by the FIVA device; VAS assessment of ease of use of the FIVA; Assessment of audial alarm of the FIVA.
Receives: Device: Fluid Intravenous Alert (FIVA) 'off'

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of undetected dry IV bags

    Measured: For the duration of the surgery

Secondary outcomes (7)
  1. Type of surgical procedure

    Questionnaire

    Measured: Baseline

  2. Duration of surgical procedure

    Questionnaire

    Measured: Baseline

  3. Presence of air in the IV

    Questionnaire

    Measured: For the duration of surgery

  4. Number of false alarms triggered by the FIVA device during the procedure

    Measured: For the duration of surgery

  5. VAS assessment of ease of use of the FIVA

    Measured: For the duration of surgery

  6. Loudness of audial alarm of the FIVA

    Questionnaire

    Measured: For the duration of surgery

  7. Ease of use of the FIVA

    Questionnaire

    Measured: For the duration of surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2016 (estimated)
  2. Study startJan 2015
  3. Primary completionDec 2017
  4. Study completionDec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02666027
Sponsor's protocol ID
NSHA REB ROMEO File#: 1019905
Acronym
FIVA
Status last verified
Jul 2018
First submitted
5 Nov 2015
Last updated
19 Jul 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Janakan G, Ellis H. Dr Thomas Aitchison Latta (c1796-1833): pioneer of intravenous fluid replacement in the treatment of cholera. J Med Biogr. 2013 May;21(2):70-4. doi: 10.1258/jmb.2012.012004.

    PubMed 24585745
  • Matern U, Koneczny S. Safety, hazards and ergonomics in the operating room. Surg Endosc. 2007 Nov;21(11):1965-9. doi: 10.1007/s00464-007-9396-4. Epub 2007 May 5.

    PubMed 17483989
  • Hung OR, Comeau. L. Incidence of intra-operative cessation of intravenous (iv) fluid administration. Can J Anesth 1998;45:A5.

  • Mendenhall ML, Spain DA. Venous air embolism and pressure infusion devices. J Trauma. 2007 Jul;63(1):246. doi: 10.1097/01.ta.0000210439.64958.df. No abstract available.

    PubMed 17622901
  • Mirski MA, Lele AV, Fitzsimmons L, Toung TJ. Diagnosis and treatment of vascular air embolism. Anesthesiology. 2007 Jan;106(1):164-77. doi: 10.1097/00000542-200701000-00026.

    PubMed 17197859
  • Pant D, Narani KK, Sood J. Significant air embolism: A possibility even with collapsible intravenous fluid containers when used with rapid infuser system. Indian J Anaesth. 2010 Jan;54(1):49-51. doi: 10.4103/0019-5049.60498.

    PubMed 20532073

Questions about this trial

What is this clinical trial studying?

A study testing Fluid Intravenous Alert (FIVA) 'on' and Fluid Intravenous Alert (FIVA) 'off' in people with Anesthesia, run by Nova Scotia Health Authority.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of undetected dry IV bags (time frame: For the duration of the surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02666027, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
FIVA Clinical Trial NCT02666027 | AzTrials